Movement Alert｜GENSCRIPT BIO Falls 3.29% in Regular Trading, Medical Sector Faces Continued Correction Pressure

Market Focus

Yesterday

On October 9, GENSCRIPT BIO fell 3.29% in regular trading, trading at 39.36 HKD/share, with Turnover of 559 million HKD. The stock extended weakness following a sharp drop in overnight U.S. pharmaceutical stocks after Allist Pharmaceuticals announced the failure of its global Phase III trial for furmonertinib, dragging sentiment across Hong Kong's pharmaceutical and biotech sectors.

GENSCRIPT BIO, a leading AIDD concept stock, has faced sustained pressure after a nearly 270% cumulative gain from early July to October 6, prompting some institutions to take profits at high levels. FMR LLC increased its stake on October 2 at an average price of 43.2187 HKD per share, raising its long position to 6.01%. The company provides life science research products and services, covering life science services, biologics development, industrial synthetic biology products, and cell therapy segments.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1132266996"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1132266996\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1132266996?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-09 10:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132266996","market":"us","top_or_hot":-1,"title":"Movement Alert｜GENSCRIPT BIO Falls 3.29% in Regular Trading, Medical Sector Faces Continued Correction Pressure","media":"Market Focus","content":"<p><p>On October 9, GENSCRIPT BIO fell 3.29% in regular trading, trading at 39.36 HKD/share, with Turnover of 559 million HKD. The stock extended weakness following a sharp drop in overnight U.S. pharmaceutical stocks after Allist Pharmaceuticals announced the failure of its global Phase III trial for furmonertinib, dragging sentiment across Hong Kong's pharmaceutical and biotech sectors.</p><p>GENSCRIPT BIO, a leading AIDD concept stock, has faced sustained pressure after a nearly 270% cumulative gain from early July to October 6, prompting some institutions to take profits at high levels. FMR LLC increased its stake on October 2 at an average price of 43.2187 HKD per share, raising its long position to 6.01%. The company provides life science research products and services, covering life science services, biologics development, industrial synthetic biology products, and cell therapy segments.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜GENSCRIPT BIO Falls 3.29% in Regular Trading, Medical Sector Faces Continued Correction Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜GENSCRIPT BIO Falls 3.29% in Regular Trading, Medical Sector Faces Continued Correction Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-09 10:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 9, GENSCRIPT BIO fell 3.29% in regular trading, trading at 39.36 HKD/share, with Turnover of 559 million HKD. The stock extended weakness following a sharp drop in overnight U.S. pharmaceutical stocks after Allist Pharmaceuticals announced the failure of its global Phase III trial for furmonertinib, dragging sentiment across Hong Kong's pharmaceutical and biotech sectors.</p><p>GENSCRIPT BIO, a leading AIDD concept stock, has faced sustained pressure after a nearly 270% cumulative gain from early July to October 6, prompting some institutions to take profits at high levels. FMR LLC increased its stake on October 2 at an average price of 43.2187 HKD per share, raising its long position to 6.01%. The company provides life science research products and services, covering life science services, biologics development, industrial synthetic biology products, and cell therapy segments.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01548","symbol_name":"金斯瑞生物科技","start_time":0,"source_url":"","article_id":"1132266996","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132266996","pubTimestamp":1791511426,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 9, GENSCRIPT BIO fell 3.29% in regular trading, trading at 39.36 HKD/share, with Turnover of 559 million HKD. The stock extended weakness following a sharp drop in overnight U.S....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01548":"金斯瑞生物科技"},"translate_title":"走势预警|金斯瑞生物常规交易下跌3.29%，医疗板块面临持续回调压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"On October 9, GENSCRIPT BIO fell 3.29% in regular trading, trading at 39.36 HKD/share, with Turnover of 559 million HKD. The stock extended weakness following a sharp drop in overnight U.S. pharmaceutical stocks after Allist Pharmaceuticals announced the failure of its global Phase III trial for furmonertinib, dragging sentiment across Hong Kong's pharmaceutical and biotech sectors.GENSCRIPT BIO, a leading AIDD concept stock, has faced sustained pressure after a nearly 270% cumulative gain from early July to October 6, prompting some institutions to take profits at high levels. FMR LLC increased its stake on October 2 at an average price of 43.2187 HKD per share, raising its long position to 6.01%. The company provides life science research products and services, covering life science services, biologics development, industrial synthetic biology products, and cell therapy segments.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}